167 related articles for article (PubMed ID: 18586023)
1. Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
Tawa M; Fukumoto T; Ohkita M; Matsumura Y
Eur J Pharmacol; 2008 Sep; 591(1-3):182-8. PubMed ID: 18586023
[TBL] [Abstract][Full Text] [Related]
2. Effects of exogenous big endothelin-1 on postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
Tawa M; Fukumoto T; Ohkita M; Yamashita N; Geddawy A; Imamura T; Ayajiki K; Okamura T; Matsumura Y
Hypertens Res; 2011 Feb; 34(2):218-24. PubMed ID: 21048781
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
Circulation; 2005 Jan; 111(3):302-9. PubMed ID: 15642760
[TBL] [Abstract][Full Text] [Related]
4. Effects of ET(A) and ET(B) receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts.
Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S394-7. PubMed ID: 15838330
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.
Matsumura Y; Kuro T; Kobayashi Y; Umekawa K; Ohashi N; Takaoka M
Jpn J Pharmacol; 2000 Sep; 84(1):16-24. PubMed ID: 11043448
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme.
Umekawa K; Hasegawa H; Tsutsumi Y; Sato K; Matsumura Y; Ohashi N
Jpn J Pharmacol; 2000 Sep; 84(1):7-15. PubMed ID: 11043447
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart.
Fukumoto T; Tawa M; Yamashita N; Ohkita M; Matsumura Y
Eur J Pharmacol; 2013 Jan; 699(1-3):74-80. PubMed ID: 23219795
[TBL] [Abstract][Full Text] [Related]
8. Role of superoxide production in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
Koyama T; Tawa M; Yamagishi N; Tsubota A; Sawano T; Ohkita M; Matsumura Y
Eur J Pharmacol; 2013 Jul; 711(1-3):36-41. PubMed ID: 23628722
[TBL] [Abstract][Full Text] [Related]
9. Different effects of AT1 receptor antagonist and ET(A) receptor antagonist on ischemia-induced norepinephrine release in rat hearts.
Fukumoto T; Tawa M; Kitada K; Yamashita N; Ohkita M; Okamura T; Matsumura Y
J Cardiovasc Pharmacol; 2012 Jul; 60(1):55-60. PubMed ID: 22494993
[TBL] [Abstract][Full Text] [Related]
10. Contribution of nitric oxide in big endothelin-1-induced cardioprotective effects on ischemia/reperfusion injury in rat hearts.
Tawa M; Fukumoto T; Ohkita M; Yamashita N; Geddawy A; Imamura T; Ayajiki K; Okamura T; Matsumura Y
J Cardiovasc Pharmacol; 2011 May; 57(5):575-8. PubMed ID: 21326108
[TBL] [Abstract][Full Text] [Related]
11. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts.
Maczewski M; Beresewicz A
J Mol Cell Cardiol; 2000 Feb; 32(2):297-310. PubMed ID: 10722805
[TBL] [Abstract][Full Text] [Related]
12. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
Matsumoto T; Ozawa Y; Taguchi K; Kobayashi T; Kamata K
Peptides; 2010 Feb; 31(2):346-53. PubMed ID: 19962413
[TBL] [Abstract][Full Text] [Related]
13. Postconditioning improves postischemic cardiac dysfunction independently of norepinephrine overflow after reperfusion in rat hearts: comparison with preconditioning.
Tawa M; Fukumoto T; Yamashita N; Ohkita M; Ayajiki K; Okamura T; Matsumura Y
J Cardiovasc Pharmacol; 2010 Jan; 55(1):6-13. PubMed ID: 19786893
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in postischemic cardiac dysfunction and norepinephrine overflow in rat heart: the role of estrogen against myocardial ischemia-reperfusion damage via an NO-mediated mechanism.
Fukumoto T; Yamashita N; Tawa M; Ohkita M; Matsumura Y
J Cardiovasc Pharmacol; 2012 Sep; 60(3):269-75. PubMed ID: 22635075
[TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats.
Hassan M; Kashimura H; Matsumaru K; Nakahara A; Fukutomi H; Muto H; Goto K; Tanaka N
Life Sci; 1997; 61(10):PL 141-7. PubMed ID: 9296343
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin-A receptors in ischemic contracture and reperfusion injury.
Brunner F; Opie LH
Circulation; 1998 Feb; 97(4):391-8. PubMed ID: 9468213
[TBL] [Abstract][Full Text] [Related]
17. Effects of phosphoramidon, BQ 788, and BQ 123 on coronary and cardiac dysfunctions of the failing hamster heart.
Fontaine ER; Viau S; Jasmin G; Dumont L
J Cardiovasc Pharmacol; 1998 Jul; 32(1):12-20. PubMed ID: 9676715
[TBL] [Abstract][Full Text] [Related]
18. Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart.
Brunner F
J Mol Cell Cardiol; 1997 Sep; 29(9):2363-74. PubMed ID: 9299360
[TBL] [Abstract][Full Text] [Related]
19. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
Xia Z; Kuo KH; McNeill JH; Ansley DM
Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840
[TBL] [Abstract][Full Text] [Related]
20. Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries.
Goel A; Su B; Flavahan S; Lowenstein CJ; Berkowitz DE; Flavahan NA
Circ Res; 2010 Jul; 107(2):242-51. PubMed ID: 20522806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
